These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16188893)

  • 1. Tubular regeneration and the role of bone marrow cells: 'stem cell therapy'--a panacea?
    De Broe ME
    Nephrol Dial Transplant; 2005 Nov; 20(11):2318-20. PubMed ID: 16188893
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution.
    Stokman G; Leemans JC; Claessen N; Weening JJ; Florquin S
    J Am Soc Nephrol; 2005 Jun; 16(6):1684-92. PubMed ID: 15829714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular engraftment and myofibroblast differentiation of recipient-derived cells after experimental kidney transplantation.
    Broekema M; Harmsen MC; Koerts JA; van Kooten TG; Navis G; van Luyn MJ; Popa ER
    Transplantation; 2007 Oct; 84(8):1003-11. PubMed ID: 17989606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow plasticity revisited: protection or differentiation in the kidney tubule?
    Krause D; Cantley LG
    J Clin Invest; 2005 Jul; 115(7):1705-8. PubMed ID: 16007248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune modulation and graft protection by gene therapy in kidney transplantation.
    Sandovici M; Deelman LE; de Zeeuw D; van Goor H; Henning RH
    Eur J Pharmacol; 2008 May; 585(2-3):261-9. PubMed ID: 18410915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the role of bone marrow-derived stem cells in renal repair.
    Huls M; Russel FG; Masereeuw R
    Kidney Blood Press Res; 2008; 31(2):104-10. PubMed ID: 18354259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic Conditioning in Kidney Transplantation.
    Veighey K; MacAllister R
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):330-336. PubMed ID: 28395520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of stem cells in kidney disease.
    Chhabra P; Brayman KL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation.
    Guan X; Dei-Anane G; Liang R; Gross ML; Nickkholgh A; Kern M; Ludwig J; Zeier M; Büchler MW; Schmidt J; Schemmer P
    J Surg Res; 2008 May; 146(1):127-34. PubMed ID: 18061615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of peripheral-type benzodiazepine receptor during ischemia reperfusion injury in a pig kidney model: a new partner of leukemia inhibitory factor in tubular regeneration.
    Zhang K; Desurmont T; Goujon JM; Favreau F; Cau J; Deretz S; Mauco G; Carretier M; Papadopoulos V; Hauet T
    J Am Coll Surg; 2006 Sep; 203(3):353-64. PubMed ID: 16931308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of renal tubular regeneration in acute kidney injury].
    Terada Y; Ueda S; Shimamura Y; Ogata K; Inoue K
    Nihon Jinzo Gakkai Shi; 2010; 52(5):558-61. PubMed ID: 20715586
    [No Abstract]   [Full Text] [Related]  

  • 12. Recipient-derived cells in the tissue repair of renal allografts.
    Wu Y; Liu Z; Ji S; Chen J; Zeng C; Li L
    Transplantation; 2006 Mar; 81(5):756-9. PubMed ID: 16534479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy for the kidney?
    Zubko R; Frishman W
    Am J Ther; 2009; 16(3):247-56. PubMed ID: 19092639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury.
    da Silva LB; Palma PV; Cury PM; Bueno V
    Int Immunopharmacol; 2007 Dec; 7(13):1609-16. PubMed ID: 17996670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of stem cells to renal repair after ischemia/reperfusion].
    Baud L; Haymann JP; Bellocq A; Fouqueray B
    Bull Acad Natl Med; 2005 Apr; 189(4):635-43; discussion 643-4. PubMed ID: 16245682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-retaining cells and tubular regeneration in postischaemic kidney.
    Vansthertem D; Caron N; Declèves AE; Cludts S; Gossiaux A; Nonclercq D; Flamion B; Legrand A; Toubeau G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3786-97. PubMed ID: 18678561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury.
    Domanski L; Sulikowski T; Safranow K; Pawlik A; Olszewska M; Chlubek D; Urasinska E; Ciechanowski K
    Eur J Pharm Sci; 2006 Mar; 27(4):320-7. PubMed ID: 16387483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of bone marrow-derived stem cells suppresses cellular necrosis and apoptosis induced by reperfusion of ischaemic kidneys in rats.
    Wang Y; Hu F; Wang ZJ; Wang GX; Zhang ZH; Xie P; Cui SP
    Chin Med J (Engl); 2008 Feb; 121(3):268-71. PubMed ID: 18298923
    [No Abstract]   [Full Text] [Related]  

  • 19. Can patient-specific stem cell therapy enhance renal repair?
    Razzaque MS
    Nephrol Dial Transplant; 2008 Jun; 23(6):1826-30. PubMed ID: 18310601
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver graft protection by antiapoptotic drugs: a step further.
    Georgiev P; Clavien PA; Gores GJ
    Liver Transpl; 2007 Mar; 13(3):318-20. PubMed ID: 17318874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.